Where are you?
To give you the most accurate information about our products and what we can do for you, we need to direct you to the right site.
USA
International
Media and Investors Resources
Press Release, 9 April 2019
Kuros Biosciences enters convertible bond financing agreement for up to CHF 5 million
Press Release, 13 March 2019
Kuros Biosciences receives US marketing clearance for intervertebral body fusion device
Press Release, 11 February 2019
Kuros Biosciences signs agreement to supply SeaSpine with bone graft incorporating Kuros's advanced submicron surface technology
Press Release, 17 December 2018
Kuros ends transformational year with first MagnetOs sales, lead clinical program on track, and successful capital raise
Press Release, 13 December 2018
Kuros announces final result of capital increase – total gross proceeds of 16.1 million raised
Press Release, 12 December 2018
Kuros announces results of rights offering – capital increase will be implemented